These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 1184241)

  • 21. A role for T lymphocytes in the antitumour action of systemic C. parvum.
    McBride WH; Peters LJ; Mason KA; Milas L
    Dev Biol Stand; 1977 Apr 13-15; 38():253-7. PubMed ID: 305374
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of antimetastatic effect against Lewis lung carcinoma after intratumoral and intravenous injections of cell-wall skeleton of Propionibacterium acnes C7 in C57BL/6 mice.
    Tanio Y; Sohma H; Tokushima Y; Nishimura K; Saiki I; Azuma I
    Gan; 1984 Mar; 75(3):237-44. PubMed ID: 6609859
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mchanisms of antitumor action of Corynebacterium parvum: nonspecific tumor cell destruction at site of immunologically mediated sensitivity reaction to C. parvum.
    Tuttle RL; North RJ
    J Natl Cancer Inst; 1975 Dec; 55(6):1403-11. PubMed ID: 1206760
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunity to transplantable nitrosourea-induced neurogenic tumors. I. Potentiation of tumor immunity with Corynebacterium parvum.
    Cravioto HM; DeBernardo E; Hochwald GM; Thorbecke JG
    J Neuropathol Exp Neurol; 1981 Sep; 40(5):526-36. PubMed ID: 7276992
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lymphocytes generated by in vivo priming and in vitro sensitization demonstrate therapeutic efficacy against a murine tumor that lacks apparent immunogenicity.
    Shu SY; Chou T; Sakai K
    J Immunol; 1989 Jul; 143(2):740-8. PubMed ID: 2738408
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A comparison of the antitumour activities of glucans and C. parvum.
    Bomford R; Moreno C
    Dev Biol Stand; 1977 Apr 13-15; 38():291-5. PubMed ID: 608513
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of Corynebacterium parvum on tumor growth in normal and athymic (nude) mice.
    Woodruff MF; Warner NL
    J Natl Cancer Inst; 1977 Jan; 58(1):111-6. PubMed ID: 299893
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of Corynebacterium parvum and cortisone on the primary Lewis tumour and its metastases.
    Jones PD; Sadler TE; Castro JE
    Int J Cancer; 1978 Jun; 21(6):784-8. PubMed ID: 669856
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mechanisms of the potentiation of specific antitumor immunity by intratumor injection of Corynebacterium parvum.
    Miyata H; Himeno K; Nomoto K
    Cancer Res; 1983 Oct; 43(10):4670-5. PubMed ID: 6883325
    [TBL] [Abstract][Full Text] [Related]  

  • 30. C. parvum treatment of transplanted rat tumours of spontaneous origin.
    Willmott N; Pimm MV; Baldwin RW
    Int J Cancer; 1979 Sep; 24(3):323-8. PubMed ID: 385514
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rejection of mammary adenocarcinoma cell tumors in DBA/2 mice immunocompromised by thymectomy and treatment with antithymocyte serum.
    Likhite VV
    J Immunol; 1975 Jun; 114(6):1736-42. PubMed ID: 1092759
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mechanism of Inhibition of immunization with irradiated tumour cells by a large dose of Corynebacterium parvum.
    Woodruff M; Whitehead VL
    Proc R Soc Lond B Biol Sci; 1977 Jul; 197(1129):505-14. PubMed ID: 18742
    [No Abstract]   [Full Text] [Related]  

  • 33. Preventive effect of Propionibacterium acnes on metastasis in mice rendered tolerant to tumor-associated transplantation antigens.
    Fujiwara H; Tsuchida T; Tsuji Y; Hamaoka T
    Gan; 1980 Oct; 71(5):692-8. PubMed ID: 7248045
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunological mechanisms in metastatic spread and the antimetastatic effects of C. parvum.
    Jones PD; Castro JE
    Br J Cancer; 1977 May; 35(5):519-27. PubMed ID: 193547
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mechanisms of anti-tumor action of Corynebacterium parvum. I. Potentiated tumor-specific immunity and its therapeutic limitations.
    Dye ES; North RJ; Mills CD
    J Exp Med; 1981 Sep; 154(3):609-20. PubMed ID: 6974214
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of T-cell subsets in the destruction of established metastases of 13762A rat mammary adenocarcinoma.
    Howell LE; Kreider JW; Bartlett GL
    J Natl Cancer Inst; 1986 Jul; 77(1):187-93. PubMed ID: 3487670
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vivo transfer of antitumor activity by peritoneal exudate cells from mice treated with Corynebacterium parvum: reduced effect in irradiated recipients.
    Peters LJ; McBride WH; Mason KA; Hunter N; Basić I; Milas L
    J Natl Cancer Inst; 1977 Sep; 59(3):881-7. PubMed ID: 330869
    [No Abstract]   [Full Text] [Related]  

  • 38. Alteration in natural defense activity against NK-susceptible B16 melanoma cells after treatment with Corynebacterium parvum.
    Karashima A; Taniguchi K; Yoshikai Y; Nomoto K
    Immunobiology; 1991 Aug; 182(5):414-24. PubMed ID: 1916884
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Enhanced Fc receptor expression by a sub-population of murine intra-tumour macrophages following intravenous Corynebacterium parvum therapy.
    Moore K; McBride WH
    Br J Cancer; 1983 Jun; 47(6):797-802. PubMed ID: 6860547
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antitumor immunity induced by hybrid murine tumor cells: requirements for optimal immunization.
    McCune CS; O'Donnell RW; Horan PK; Budd HS; Spennacchio JL; Chuang C; Henshaw EC
    J Natl Cancer Inst; 1982 Sep; 69(3):647-52. PubMed ID: 6955557
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.